Weil, Gotshal & Manges advised Halozyme, while Skadden, Arps, Slate, Meagher & Flom advised Antares Pharma on the deal. Fried Frank acted as counsel to BofA...
Halozyme Therapeutics’ Acquisition of Antares Pharma
Thoma Bravo’s $2.6 Billion Acquisition of Bottomline Technologies
Skadden, Arps, Slate, Meagher & Flom and Wilmer Cutler Pickering Hale and Dorr represented Bottomline, while Kirkland & Ellis represented Thoma Bravo in the transaction. Debevoise...
Novo Nordisk’s Acquisition of Dicerna Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom advised Dicerna Pharmaceuticals on the deal. Davis Polk & Wardwell advised Evercore. Dicerna Pharmaceuticals, Inc., has entered into a definitive agreement...
AspenTech’s Merger With Emerson Electric Co.’s
Simpson Thacher advised JPMorgan as financial advisor on the deal, while Davis Polk advised Emerson. Skadden, Arps, Slate, Meagher & Flom advised AspenTech. Aspen Technology, Inc....
MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Xeris Pharmaceuticals’ Acquisition of Strongbridge Biopharma
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
Alcon’s Acquisition of U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Skadden, Arps, Slate, Meagher & Flom LLP advised Alcon on the deal. Alcon, the global leader in eye care dedicated to helping people see brilliantly, has...